Compare Maxindo Karya Anugerah Tbk. (MAXI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maxindo Karya Anugerah Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Maxindo Karya Anugerah Tbk. trades at Rp50 (market cap 480.5B, 80.1K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 216.9K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 26.2× Maxindo Karya Anugerah Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (216.9K versus 80.1K). Which is the better fit depends on your goals.
| MAXI | TSPC | |
|---|---|---|
Market Cap | 480.5B | 12.58T |
Volume | 80.1K | 216.9K |
Lot | 801 | 2.17K |
Turnover | 4.01M | 599M |
Average Price | 50 | 2,761.65 |
Value | 4.01M | 599M |
Indicative Equilibrium Price | 50 | 2,790 |
Indicative Equilibrium Volume | 12.7K | 3.9K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maxindo Karya Anugerah Tbk.
PT Maxindo Karya Anugerah Tbk (the Company) was established based on Notarial Deed No. 26 of Dwi Swandiani, S.H., dated July 11, 2002. The Company started its commercial operations in 2002.
Read more on MAXI →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
